CN Stock MarketDetailed Quotes

603963 Dali Pharmaceutical

Watchlist
  • 2.08
  • -0.11-5.02%
Market Closed Jan 10 14:54 CST
456.98MMarket Cap-18.74P/E (TTM)

About Dali Pharmaceutical Company

The company was restructured and established in October 1996, and changed to a foreign-invested company limited by shares in January 2008. On September 22, 2017, the company's initial public offering of A-shares was officially listed on the main board of the Shanghai Stock Exchange. It became the first company listed on the A-share main board in Dali Prefecture and one of the few listed pharmaceutical companies in Yunnan Province. The company's main business is the production and sale of traditional Chinese medicine injections and the commercial distribution of pharmaceuticals. The company's main products are “Zhongjing” Xinming Injection and Shenmai Injection, and the “Zhongjing Zhongjing and Figure” trademark is a well-known trademark in China. Company honors include: Innovative Enterprises in Yunnan Province, Excellent Industrial Enterprises in Yunnan Province, Clean Production Enterprises, and Advanced Quality and Efficiency Enterprises in Yunnan Province.

Company Profile

Short Name-A*ST大药
Symbol-A603963
Company NameDali Pharmaceutical Co.,Ltd
Listing DateSep 22, 2017
Issue Price12.58
Shares Offered25.00M share(s)
FoundedMar 22, 2004
Listed ExchangeSH Stock Exchange
Legal Representativecuixiandai yin
General Managerpeirongdai wu
Secretarypeirong wu
Accounting FirmShinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)
Securities Representativeliyao xu
Legal CounselShanghai Tongli Law Firm
Employees265
Phone0872-8880055
Office Address118 Huancheng West Road, Xiaguan, Dali, Yunnan
Zip Code671000
Registered Address118 Huancheng West Road, Xiaguan, Dali City, Dali Bai Autonomous Prefecture, Yunnan Province
Fax0872-8880055
Emaildongban@daliyaoye.cn
Websitehttp://www.daliyaoye.cn
Business License532900400008869
BusinessLicense projects: pharmaceutical production; pharmaceutical wholesale; pharmaceutical retail; pharmaceutical contract production; pharmaceutical import/export; cosmetics production; hygiene products and disposable medical supplies production; health food production; food sales; Class II medical device production; Class III medical device production; Class III medical device management (projects subject to approval by law can only be carried out after approval by relevant departments. Specific business projects are subject to relevant department approval documents or licenses) General projects: cosmetics wholesale; cosmetics retail; hygiene products and disposable medical supplies sales; health care Food (pre-packaged) sales; first-class medical device sales; first-class medical device sales; second-class medical device sales; daily mask (non-medical) production; daily mask (non-medical) sales; labor protection products sales; medical packaging material manufacturing; packaging materials and product sales; non-residential real estate leasing (except for projects subject to approval by law, independently carrying out business activities based on a business license in accordance with law). (Except where national regulations are required to implement special management measures for entry)

Company Executives

  • Name
  • Position
  • Salary
  • junxiang yang
  • Chairman, Directors, General Manager, Chairman of the Strategy Committee
  • 583.30K
  • cuixian yin
  • Acting Chairman, Vice Chairman, Directors, Acting Chairman of the Strategy Committee
  • 400.00K
  • lihua ceng
  • Vice Chairman, Directors, Strategy Committee Member, Audit Committee Member
  • 240.00K
  • jiyao ceng
  • Directors, Member of the Remuneration and Assessment Committee
  • 80.00K
  • junwei yang
  • Directors, Nomination Committee Members, Strategy Committee Member
  • 236.50K
  • wei yuan
  • Directors, Strategy Committee Member
  • 160.00K
  • ronghui yao
  • Independent Directors, Chairman of the Audit Committee, Nomination Committee Members
  • 41.70K
  • yulan li
  • Independent Directors, Strategy Committee Member, Chairman of the Remuneration and Assessment Committee, Audit Committee Member
  • 41.70K
  • quanliang dong
  • Independent Directors, Member of the Remuneration and Assessment Committee, Chairman of the Nomination Committee
  • 100.00K
  • peirong wu
  • Board Secretary, Acting General Manager
  • --
  • liyao xu
  • Securities Affairs Representative
  • --
  • xin liu
  • Chairman of the Supervisory Board, Shareholder Supervisors
  • 66.70K
  • huaying xin
  • Shareholder Supervisors
  • 55.80K
  • shaoyun li
  • Deputy General Manager, Chief Financial Officer
  • 347.70K
  • zhuomei gao
  • Employee Supervisors
  • 36.00K
Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme ST concept
ST concept
Intraday-1.08%